1. Home
  2. VRAX vs CETX Comparison

VRAX vs CETX Comparison

Compare VRAX & CETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • CETX
  • Stock Information
  • Founded
  • VRAX 2013
  • CETX 1998
  • Country
  • VRAX United Kingdom
  • CETX United States
  • Employees
  • VRAX N/A
  • CETX N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CETX EDP Services
  • Sector
  • VRAX Health Care
  • CETX Technology
  • Exchange
  • VRAX Nasdaq
  • CETX Nasdaq
  • Market Cap
  • VRAX 4.4M
  • CETX 4.1M
  • IPO Year
  • VRAX 2022
  • CETX 1998
  • Fundamental
  • Price
  • VRAX $0.55
  • CETX $0.83
  • Analyst Decision
  • VRAX Strong Buy
  • CETX
  • Analyst Count
  • VRAX 1
  • CETX 0
  • Target Price
  • VRAX $3.00
  • CETX N/A
  • AVG Volume (30 Days)
  • VRAX 1.4M
  • CETX 1.1M
  • Earning Date
  • VRAX 01-01-0001
  • CETX 08-14-2025
  • Dividend Yield
  • VRAX N/A
  • CETX N/A
  • EPS Growth
  • VRAX N/A
  • CETX N/A
  • EPS
  • VRAX N/A
  • CETX N/A
  • Revenue
  • VRAX $6,331.00
  • CETX $76,095,551.00
  • Revenue This Year
  • VRAX $217,274.83
  • CETX $19.77
  • Revenue Next Year
  • VRAX N/A
  • CETX $15.00
  • P/E Ratio
  • VRAX N/A
  • CETX N/A
  • Revenue Growth
  • VRAX N/A
  • CETX 16.50
  • 52 Week Low
  • VRAX $0.52
  • CETX $0.85
  • 52 Week High
  • VRAX $4.44
  • CETX $381.57
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 29.17
  • CETX 23.80
  • Support Level
  • VRAX $0.52
  • CETX $0.87
  • Resistance Level
  • VRAX $0.65
  • CETX $1.34
  • Average True Range (ATR)
  • VRAX 0.05
  • CETX 0.08
  • MACD
  • VRAX -0.01
  • CETX -0.04
  • Stochastic Oscillator
  • VRAX 10.32
  • CETX 5.53

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

Share on Social Networks: